VEON (NASDAQ:VEON) reported quarterly sales of $2.08 million which missed the analyst consensus estimate of $2.05 billion by 99.90 percent. This is a 99.90 percent decrease over sales of $2.00 billion the same period last year.
Why CNS Pharmaceuticals Shares Are Trading Higher
CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares are trading higher by 15.47% to $1.00 after the company announced it received approval from the Competent Authority and the central Ethics Committee in Italy for its potentially pivotal global trial evaluating Berubicin for the treatment of GBM.
